Navegar

Colección

Datos Estadísticas

Lista de

Mice, Nude
26
"Antitumor effectiveness of a combined therapy with a new cucurbitacin B derivative and paclitaxel on a human lung cancer xenograft model" (2017) Marostica, L.L.;de Barros, A.L.B.;Oliveira, J. (...)Simões, C.M.O. Toxicology and Applied Pharmacology. 329:272-281
"CtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAs" (2016) De Luca, P.;Dalton, G.N.;Scalise, G.D. (...)De Siervi, A. Oncotarget. 7(14):18798-18811
"RSUME is implicated in tumorigenesis and metastasis of pancreatic neuroendocrine tumors" (2016) Wu, Y.;Tedesco, L.;Lucia, K. (...)Stalla, G.K. Oncotarget. 7(36):57878-57893
"Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells" (2016) Castillo, L.F.;Tascón, R.;Huvelle, M.A.L. (...)Peters, M.G. Oncotarget. 7(37):60133-60154
"Low doses of CPS49 and flavopiridol combination as potential treatment for advanced prostate cancer" (2015) Zalazar, F.;De Luca, P.;Gardner, K. (...)De Siervi, A. Current Pharmaceutical Biotechnology. 16(6):553-563
"RSUME inhibits VHL and regulates its tumor suppressor function" (2015) Gerez, J.;Tedesco, L.;Bonfiglio, J.J. (...)Arzt, E. Oncogene. 34(37):4855-4866
"OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis" (2014) Astorgues-Xerri, L. European journal of cancer (Oxford, England : 1990). 50(14):2463-2477
"Prostate tumor growth is impaired by CtBP1 depletion in high-fat diet-fed mice" (2014) Moiola, C.P.;Luca, P.D.;Zalazar, F. (...)De Siervi, A. Clinical Cancer Research. 20(15):4086-4095
"Antitumor activity of histamine and clozapine in a mouse experimental model of human melanoma" (2013) Massari, N.A.;Medina, V.A.;Cricco, G.P. (...)Rivera, E.S. Journal of Dermatological Science. 72(3):252-262
"Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma" (2012) Croci, D.O.;Salatino, M.;Rubinstein, N. (...)Rabinovich, G.A. Journal of Experimental Medicine. 209(11):1985-2000
"H2O2 scavenging inhibits G1/S transition by increasing nuclear levels of p27KIP1" (2011) Ibañez, I.L.;Policastro, L.L.;Tropper, I. (...)Durán, H. Cancer Letters. 305(1):58-68
"Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer" (2011) Ferrando, M.;Gueron, G.;Elguero, B. (...)Vazquez, E. Angiogenesis. 14(4):467-479
"c-Jun regulates phosphoinositide-dependent kinase 1 transcription: Implication for Akt and protein kinase C activities melanoma tumorigenesis" (2010) Lopez-Bergami, P.;Kim, H.;Dewing, A. (...)Ronai, Z. Journal of Biological Chemistry. 285(2):903-913
"Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo" (2009) Schaaf, C.;Shan, B.;Buchfelder, M. (...)Renner, U. Endocrine-Related Cancer. 16(4):1339-1350
"Inhibition of heme oxygenase-1 interferes with the transforming activity of the Kaposi sarcoma herpesvirus-encoded G protein-coupled receptor" (2006) Marinissen, M.J.;Tanos, T.;Bolós, M. (...)Cuadrado, A. Journal of Biological Chemistry. 281(16):11332-11346
"Involvement of the gp130 cytokine transducer in MtT/S pituitary somatotroph tumour development in an autocrine-paracrine model" (2004) Graciarena, M.;Carbia-Nagashima, A.;Onofri, C. (...)Arzt, E. European Journal of Endocrinology. 151(5):595-604
"Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk" (2003) Páez-Pereda, M.;Giacomini, D.;Refojo, D. (...)Arzt, E. Proceedings of the National Academy of Sciences of the United States of America. 100(3):1034-1039
"New mechanisms involved in the pathogenesis of pituitary adenomas " (2003) Giacomini, D.;Paez-Pereda, M.;Refojo, D. (...)Arzt, E. Medicina. 63(2):147-150
"The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo." (1998) Bover, L.;Barrio, M.;Bravo, A.I. (...)Mordoh, J. Cellular and molecular biology (Noisy-le-Grand, France). 44(3):493-504
"Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model." (1996) Ledda, M.F.;Adris, S.;Bravo, A.I. (...)Podhajcer, O.L. Cellular and molecular biology (Noisy-le-Grand, France). 42(5):769-778
"Anti-tumor activity of cytokines against opportunistic vascular tumors in mice" (1996) Dong, Q.G.;Graziani, A.;Garlanda, C. (...)Bussolino, F. International Journal of Cancer. 65(5):700-708
"Biologic, Immunocytochemical, and Cytogenetic Characterization of Two New Human Melanoma Cell Lines: IIB‐MEL‐LES and IIB‐MEL‐IAN" (1995) KAIRIYAMA, C.;SLAVUTSKY, I.;LARRIPA, I. (...)MORDOH, J. Pigment Cell Research. 8(3):121-131
"Description of a new human breast cancer cell line, IIB-BR-G, established from a primary undifferentiated tumor" (1991) Bover, L.;Barrio, M.;Slavutsky, I. (...)Mordoh, J. Breast Cancer Research and Treatment. 19(1):47-56